Marc Humbert (Paris, France), H. Ardeschir Ghofrani (Giessen, Germany)
LATE-BREAKING ABSTRACT: Pulmonary vascular effects after pulsed inhaled NO evaluated by functional respiratory imaging (FRI)
Bita Hajian (Amsterdam, Netherlands), Bita Hajian, Francisca Ferreira, Wim Vos, Jan De Backer, Cedric Van Holsbeke, Douglas Greene, Reinilde Heyrman, Wilfried De Backer
|  |
Initial combination therapy with ambrisentan (AMB) and tadalafil (TAD) in treatment naïve patients with pulmonary arterial hypertension (PAH): Efficacy and safety in the AMBITION study intent to treat (ITT) population
Marius M. Hoeper (Hannover, Germany), Marius Hoeper, Nazzareno Galie, Joan Albert Barbera, Adaani Frost, Ardeschir Ghofrani, Valerie McLaughlin, Andrew Peacock, Gerald Simonneau, Jean-Luc Vachiery, Christiana Blair, Hunter Gillies, Julia Harris, Jon Langley, Lewis Rubin
| |
Effect of selexipag on long-term outcomes in key subgroups of patients with pulmonary arterial hypertension (PAH): GRIPHON study results
Olivier Sitbon (Le Kremlin Bicêtre, France), Olivier Sitbon, Richard Channick, Kelly Chin, Aline Frey, Nazzareno Galiè, Hossein-Ardeschir Ghofrani, Marius M. Hoeper, Irene Lang, Franck-Olivier Le Brun, Vallerie McLaughlin, Ralph Preiss, Lewis J. Rubin, Gérald Simmonneau, Victor Tapson, Sean Gaine
| |
Upfront combination therapy in the treatment of scleroderma-associated pulmonary arterial hypertension: Results of an open label trial
Paul M. Hassoun (Baltimore, United States of America), Paul Hassoun, Roham Zamanian, Rachel Damico, Rubina Khair, Todd Kolb, Ryan Tedford, Olivia Hulm, Chiara Pisanello, Takahiro Sato, Cecilia Corona-Villalobos, Stefan Zimmerman, Mohamed Gashouta, Omar Minai, Fernando Torres, Kelly Chin, Reda Girgis, Stephen Mathai
|  |
Renal denervation reduces pulmonary vascular remodeling in two experimental pulmonary arterial hypertension models
Denielli Bos (Amsterdam, Netherlands), Denielli Da Silva Goncalves Bos, Chris Happé, Ingrid Schalij, Wioletta Pijacka, Julian F. Paton, Harm-Jan Bogaard, Nico Westerhof, Albertus C. Van Rossum, Anton Vonk-Noordegraaf, Frances S. De Man, M. Louis Handoko
|  |
Long-term outcome of sarcoidosis-associated pulmonary hypertension in the modern treatment era
Athénaïs Boucly (Paris, France), Athénaïs Boucly, Xavier Jaïs, Caroline Sattler, Andrei Seferian, David Amar, David Montani, Gerald Simonneau, Marc Humbert, Olivier Sitbon, Laurent Savale
| |
Riociguat for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Real-life data from the EXPERT registry
Michael Halank (Dresden, Germany), Michael Halank, Marc Humbert, Miguel-Angel Gomez Sanchez, David Pittrow, Marius Hoeper, Ekkehard Grünig, H. Ardeschir Ghofrani, Hubert Wirtz, Hans Klose, Ralf Ewert, Tobias J. Lange, Jens Klotsche, Christian Meier, Monika Brunn, Gerald Simonneau
| |
Pulmonary hypertension due to lung disease – Results from COMPERA
Ekkehard Grünig (Heidelberg, Germany), Ekkehard Grünig, Doerte Huscher, David Pittrow, Dario Vizza, Marius M. Hoeper
| |